2009
DOI: 10.1002/clc.20435
|View full text |Cite
|
Sign up to set email alerts
|

Statins as Anti‐Arrhythmics: A Systematic Review Part II: Effects on Risk of Ventricular Arrhythmias

Abstract: BackgroundRecent studies have demonstrated that statins may possess anti‐arrhythmic properties in addition to their lipid‐lowering effects.MethodsStudies which reported the association of statins with the incidence of ventricular arrhythmias were identified through a systematic review of the published literature.ResultsStatins have been associated with a significant reductions in ventricular arrhythmia in cardiomyopathy patients with an implantable cardioverter defibrillator, although randomized trials have no… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
17
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(17 citation statements)
references
References 25 publications
0
17
0
Order By: Relevance
“…Clinical trials of lipid lowering in the primary prevention of coronary artery disease have not evaluated SCD risk, and have not sufficient statistical power to identify a significant reduction (Priori et al, 2001). Statins seem to have antiarrhythmic properties in addition to their lipid-lowering effects (Chu et al 2007;Abuissa et al, 2009). Isolated metabolic syndrome is associated with an increase in left ventricular mass index and diastolic dysfunction, increasing the risk of cardiovascular disease (Aijaz et al, 2008).…”
Section: Dyslipidemia and Metabolic Syndromementioning
confidence: 99%
See 1 more Smart Citation
“…Clinical trials of lipid lowering in the primary prevention of coronary artery disease have not evaluated SCD risk, and have not sufficient statistical power to identify a significant reduction (Priori et al, 2001). Statins seem to have antiarrhythmic properties in addition to their lipid-lowering effects (Chu et al 2007;Abuissa et al, 2009). Isolated metabolic syndrome is associated with an increase in left ventricular mass index and diastolic dysfunction, increasing the risk of cardiovascular disease (Aijaz et al, 2008).…”
Section: Dyslipidemia and Metabolic Syndromementioning
confidence: 99%
“…Lipid-lowering interventions reduce coronary events, VT/VF episodes, SCD and all-cause mortality (Liu et al, 2009). Recent studies have demonstrated that statins have antiarrhythmic properties in addition to their lipid-lowering effects (Abuissa et al, 2009;Chu et al 2007;Liu et al, 2009). Kayikcioglu et al found a significant decrease of the prevalence of LVPs and ventricular arrhythmias in acute MI patients receiving pravastatin, irrespective of lipid level (Kayikcioglu et al, 2003).…”
Section: Influence Of Therapy On Lvpsmentioning
confidence: 99%
“…In addition to their role in controlling lipid levels, the pleiotropic effects of statins, including the anti-arrhythmia effects and prevention of cardiac remodeling, have attracted significant attention (1,2). A large number of studies have focused on left ventricular remodeling following myocardial infarction (MI) and the treatment effect of statins (3)(4)(5)(6).…”
Section: Introductionmentioning
confidence: 99%
“…Although there is clinical evidence that use of statins is also associated with less risk of ventricular arrhythmias (16), direct antiarrhythmic effect of statins in the ventricles has not been reported. Direct inhibition of EADS and DADs by statins in the pulmonary veins indicates that statins may potentially exert a similar protective effect in the ventricles, and a role of statins through their antiarrhythmic effects in reduction of all-cause mortality cannot be ruled out.…”
mentioning
confidence: 97%